Su H Wang, MD, FACP, MPH discusses combating vaccine misinformation, preventing outbreaks, and highlighting global health interconnectedness
Social media platforms, public health agencies, and communities must join forces to stop the rapid spread of false information.
With the addition of 2 new live biotherapeutic products, a clinician reviews the application, storage and administration techniques for them.
Findings increasingly suggest the mortality risk may be reduced by initiating daptomycin within 3 days of infection.
A study underscores the microbial etiology of septic arthritis, which can guide clinicians in minimizing the use of overly broad empiric antibiotics.
Examining pharmacological management in COVID-19 patients with ARDS requiring antifungal therapy during extracorporeal life support.
The 15th anniversary of the Affordable Care Act is overshadowed by threats to HIV prevention efforts, including a looming Supreme Court case that could eliminate no-cost access to preexposure prophylaxis and other preventive services. Simultaneously, deep federal cuts and restructuring have destabilized critical public health infrastructure, jeopardizing decades of progress in the fight against HIV.
A pair of experts assess literature on the means of interpreting hospitalized patient antibiotic resistance through machine learning.
Study results show that the vaccine elicits a comparable immune response in high-risk adults aged 18-59 with chronic medical conditions, suggesting potential for broader vaccination efforts.
As the first line of acute care, emergency departments are key stewards of antibiotics.
To meet ambitious targets for ending the HIV/AIDS epidemic, governments must unite in a global effort to improve access to CD4 testing.
Cornelius Clancy, MD, highlights the real-world outcomes of cefiderocol treatment for serious gram-negative bacterial infections, reporting a clinical success rate of 75% along with encouraging safety data.
At MAD-ID, Timothy Aungst, PharmD, outlines the role of artificial intelligence in clinical decision-making, curriculum design, and infectious disease practice.
Important clinical considerations to know about resistant CMV infections.
As the first line of acute care, emergency departments are key stewards of antibiotics.
Clinicians look at optimal approaches for trying to avoid Clostridioides difficile infection (CDI).
New therapeutics offer some hope in this emerging market.
The latest article from SIDP offers a Top 5 list of how to precept a learner on an infectious disease rotation.
There is limited and conflicting data regarding the role of combination antifungal therapy for treatment of invasive mucormycosis.
Clinicians review a patient case including diagnosis, treatment, and follow-up.
The prevalence of this disease in this patient population is much higher than in the general public.
In the latest column from SIDP, the authors discuss having leaders to help navigate school and beyond.
Phase 1 data on VH184, a third-generation integrase strand transfer inhibitor, and VH499, a novel HIV-1 capsid inhibitor, highlighting their antiviral potency, safety profiles, and potential for long-acting injectable formulations.
The limitation in the number of pediatric-specific guidelines by professional organizations, and results from large randomized clinical trials, may place an additional emphasis on literature evaluation skills for pediatric ASP pharmacists.
Experts share advice for physicians taking care of patients with C. difficile infection (CDI).
Drs Jacinda Abdul-Mutakabbir, Madeline King, Rodney Rohde, and expert nurse practitioner Wendy Wright provide insight on receiving the influenza vaccine concurrently with the SARS-CoV-2 booster shot, and comment on data on immune responses from the Moderna and Pfizer/BioNTech vaccines.
The most common reasons include finances, logistics, availability of information, and hesitancy or refusal.